Familial risks for cervical tumors in full and half siblings: etiologic apportioning
- PMID: 16835346
- DOI: 10.1158/1055-9965.EPI-05-0933
Familial risks for cervical tumors in full and half siblings: etiologic apportioning
Abstract
Many studies have shown familial aggregation for cervical cancer, but they have been unable to distinguish between shared environmental and genetic effects. Full and half-siblings were identified from the nationwide Swedish Family-Cancer Database, including invasive and in situ cervical cancers in women up to age 70 years. Half-siblings were defined through a common father or mother. Standardized incidence ratios, adjusted for several variables, were calculated for proband-wise risks between full and half-siblings. The familial risk for full siblings was 1.84, compared with 1.40 for maternal and 1.27 for paternal half-siblings. These data were used to apportion familial risk for cervical tumors in full siblings into a heritable component, accounting for 64%, and an environmental component, accounting for 36% of the total risk. No evidence for gene-environment interactions was found. The intractable difficulty in separating cervical cancer causation will be an obstacle for a successful identification of susceptibility genes.
Similar articles
-
Familial risks for asthma among twins and other siblings based on hospitalizations in Sweden.Clin Exp Allergy. 2007 Sep;37(9):1320-5. doi: 10.1111/j.1365-2222.2007.02737.x. Clin Exp Allergy. 2007. PMID: 17845412
-
Familial risks for chronic obstructive pulmonary disease among siblings based on hospitalisations in Sweden.J Epidemiol Community Health. 2008 May;62(5):398-401. doi: 10.1136/jech.2007.063156. J Epidemiol Community Health. 2008. PMID: 18413451
-
Familial risk for lung cancer by histology and age of onset: evidence for recessive inheritance.Exp Lung Res. 2005 Mar;31(2):205-15. doi: 10.1080/01902140490495606. Exp Lung Res. 2005. PMID: 15824021
-
Relationships between familial risks of cancer and the effects of heritable genes and their SNP variants.Mutat Res. 2005 Dec 30;592(1-2):6-17. doi: 10.1016/j.mrfmmm.2005.05.008. Epub 2005 Jun 28. Mutat Res. 2005. PMID: 15990124 Review.
-
Familial risks in testicular cancer as aetiological clues.Int J Androl. 2006 Feb;29(1):205-10. doi: 10.1111/j.1365-2605.2005.00599.x. Int J Androl. 2006. PMID: 16466541 Review.
Cited by
-
Genetic susceptibility to cervical cancer: role of common polymorphisms in apoptosis-related genes.Tumour Biol. 2015 Sep;36(9):6633-44. doi: 10.1007/s13277-015-3868-2. Epub 2015 Aug 5. Tumour Biol. 2015. PMID: 26242271 Review.
-
Cervix smear abnormalities: linking pathology data in female twins, their mothers and sisters.Eur J Hum Genet. 2011 Jan;19(1):108-11. doi: 10.1038/ejhg.2010.139. Epub 2010 Aug 18. Eur J Hum Genet. 2011. PMID: 20717168 Free PMC article.
-
Single nucleotide polymorphisms in the PRDX3 and RPS19 and risk of HPV persistence and cervical precancer/cancer.PLoS One. 2012;7(4):e33619. doi: 10.1371/journal.pone.0033619. Epub 2012 Apr 9. PLoS One. 2012. PMID: 22496757 Free PMC article. Clinical Trial.
-
Distribution of CCND1 A870G polymorphism in patients with advanced uterine cervical carcinoma.Pathol Oncol Res. 2011 Mar;17(1):133-7. doi: 10.1007/s12253-010-9293-3. Epub 2010 Aug 3. Pathol Oncol Res. 2011. PMID: 20680537
-
Human Leukocyte Antigen Class I and II Alleles and Cervical Adenocarcinoma.Front Oncol. 2014 Jun 19;4:119. doi: 10.3389/fonc.2014.00119. eCollection 2014. Front Oncol. 2014. PMID: 24995157 Free PMC article.